Dr. Cezar Khursigara, PhD Joins PUF Ventures Advisory Board
PUF Ventures Provides Update to Spin Out Company Cannvas MedTech Inc.
PUF Ventures Inc. Announces a Plan to Spin Out its Subsidiary Natures Hemp Inc.
PUF Ventures Announces Stock Option Grants.
Solaris Nutraceuticals Receives AUD$2,500,000 Grant from Federal Department of Innovation, Industry & Science
Cannvas Medtech Inc. Forms Technology Partnership with Blox Labs for Digital Marketing and Branding
PUF Ventures to Submit Confirmation of Readiness for a Licence Under the ACMPR for London, Ontario Facility
Puf Ventures Announces Closing Of Plan Of Arrangement With Cannvas Medtech Inc.
Australia to Allow Exportation of Cannabis Products
PUF Ventures Announces Stock Option Grants
PUF Ventures Announces Application Acceptance and Name Change of PUF Ventures Australia
PUF Ventures Australia Files for Medical Research License in Collaboration with Western Sydney University
PUF Ventures Announces Receipt of Final Order for Plan of Arrangement
PUF Ventures Reports Annual General and Special Meeting Results
PUF Ventures Australia Engages Dutch Greenhouse Builder KUBO to Construct Advanced Cannabis Production Facility
PUF Ventures Provides Corporate Update
PUF Ventures Australia Files Office of Drug Control Applications in Australia. Expands Grow Facility Plan by 20%
PUF Ventures to Acquire Hemp Based Food and Medicinal Product Lines
PUF Ventures Prepares Health Canada Proof of Readiness Submission For Grow Facility in London Ontario
PUF Ventures Provides Update to Plan of Arrangement with Weed Points Loyalty Inc.